Skip to main content
. 2023 Mar 23;4(6):e796–e808. doi: 10.34067/KID.0000000000000113

Table 2.

Adverse events, serious adverse events, and study withdrawals

Patient ID SAE Comment AE Comment Comment
IXA-1 3 Hematoma at fistula surgery site, readmitted for hematoma from fistula surgery, hematoma from end of study bone marrow aspiration 3 Common cold, latent TB, cellulitis N/A
IXA-2 1 Hematoma at bone marrow aspiration site 3 Outpatient surgery, vomiting, cough from common cold N/A
IXA-3 0 16 Paresthesia, hip pain, thrush, dermatitis, hypercholesterolemia, nausea, vomiting, headache Transplanted
IXA-4 1 Mechanical aortic valve placed 2 Paresthesia, wisdom tooth infection N/A
IXA-5 4 Bacteremia, blood clot associated with dialysis catheter, liver abscess 12 Diarrhea, chest pain, nausea, hemorrhoids, bacteremia, blood clot associated with dialysis catheter, stomach pain, liver abscess N/A
IXA-6 0 28 Postmenopausal bleeding, nausea, paresthesia, foot fracture Withdrawn from transplant waitlist and study because of frailty
IXA-7 1 Pneumonia 13 Hyperglycemia, common cold with cough and shortness of breath, insomnia, edema, shingles, hallucinations, pneumonia Lost to follow-up
IXA-8 0 4 Diarrhea, acid reflux Lost to follow-up
IXA-9 1 Alcohol intoxication 4 Irritability, alcohol intoxication Withdrawn from study and waitlist for active alcohol abuse
IXA-10 0 0 N/A Transplanted

SAE, serious adverse event; AE, adverse event TB, tuberculosis; N/A, not applicable.